Cell-free tumor DNA in blood plasma as a marker for circulating tumor cells in prostate cancer.
about
Circulating tumor cells: approaches to isolation and characterizationCell-free circulating tumor DNA in cancerWhen Prostate Cancer Circulates in the BloodstreamNew blood markers detection technology: A leap in the diagnosis of gastric cancerPrognostic and Predictive Significance of Stromal Fibroblasts and Macrophages in Colon CancerLiquid biopsies: genotyping circulating tumor DNADNA hybridization detection with 100 zM sensitivity using piezoelectric plate sensors with an improved noise-reduction algorithm.Methylation analyses in liquid biopsyCell-free DNA as a diagnostic marker for cancer: current insightsUsing circulating tumor cells to inform on prostate cancer biology and clinical utilityPerformance evaluation of kits for bisulfite-conversion of DNA from tissues, cell lines, FFPE tissues, aspirates, lavages, effusions, plasma, serum, and urine.Methylated DNA and high total DNA levels in the serum of patients with breast cancer following neoadjuvant chemotherapy are predictive of a poor prognosis.Apoptosis-related deregulation of proteolytic activities and high serum levels of circulating nucleosomes and DNA in blood correlate with breast cancer progression.Prediction of CCND1 amplification using plasma DNA as a prognostic marker in oesophageal squamous cell carcinomaAll circulating EpCAM+CK+CD45- objects predict overall survival in castration-resistant prostate cancer.Emergence of single-molecule sequencing and potential for molecular diagnostic applications.Establishment of tumor-specific copy number alterations from plasma DNA of patients with cancer.Real-time liquid biopsy: circulating tumor cells versus circulating tumor DNA.Non-invasive prenatal diagnosis of multiple endocrine neoplasia type 2A using COLD-PCR combined with HRM genotyping analysis from maternal serumCirculating Tumor Cells Count and Morphological Features in Breast, Colorectal and Prostate Cancer.Mass spectrometric based analysis, characterization and applications of circulating cell free DNA isolated from human body fluidsCirculating cell-free AR and CYP17A1 copy number variations may associate with outcome of metastatic castration-resistant prostate cancer patients treated with abiraterone.The presence of disseminated tumour cells in the bone marrow is inversely related to circulating free DNA in plasma in breast cancer dormancy.Circulating nucleic acids in plasma and serum: diagnosis and prognosis in cancerBiomarkers for the Management of Castration-Resistant Prostate Cancer: We Are Not There Yet.Tumor-Related Methylated Cell-Free DNA and Circulating Tumor Cells in Melanoma.Functional analysis of androgen receptor mutations that confer anti-androgen resistance identified in circulating cell-free DNA from prostate cancer patients.High-resolution imaging for the detection and characterisation of circulating tumour cells from patients with oesophageal, hepatocellular, thyroid and ovarian cancers.The potential for liquid biopsies in the precision medical treatment of breast cancer.Detecting circulating tumor cells: current challenges and new trends.Comparison of four DNA extraction methods for detecting Mycobacterium tuberculosis by real-time PCR and its clinical application in pulmonary tuberculosis.Blood and tissue biomarkers in prostate cancer: state of the art.The clinical utilization of circulating cell free DNA (CCFDNA) in blood of cancer patients.Development of a method to isolate circulating tumor cells using mesenchymal-based capture.Liquid Biopsies for Assessing Metastatic Melanoma Progression.Circulating nucleic acids as biomarkers in breast cancer.Methylated DNA/RNA in Body Fluids as Biomarkers for Lung Cancer.Biomarkers in cancer micrometastasis: where are we at?Tracing the origins of metastasis.Organ-specific markers in circulating tumor cell screening: an early indicator of metastasis-capable malignancy.
P2860
Q24631347-242886EA-5CCB-424E-8838-4E6850B462CCQ26750899-1CFA7473-5372-45F6-A48F-19A53BB91C45Q26768470-E0C6A91A-5D87-4CB3-B68A-F45527C7444FQ26774503-99AA58AF-D4BC-4678-860B-560F350D0928Q26777108-25741694-2498-4FE0-8387-F45EC5D0FABAQ27010159-41E3F0F9-A952-4CC7-855B-0A975D1163ECQ27336155-C89B2AB7-474B-4229-96AE-C5807EE01071Q28072859-AB18D92B-2DF8-46AF-8AAF-C9C5964DB8B2Q28074556-383CC4A2-34ED-4DCA-B996-EA5EF7276904Q28083261-916B9B28-A64C-4AE0-B328-896213F3727DQ31157538-9FBD1D13-8CB0-4A85-9537-E0D06C00AFBDQ33778433-B049FC53-223A-4742-AE1B-2AEE61559B52Q33787458-DE743777-6B3C-41E2-A3ED-37D2AC3C5D20Q33834440-6D4809E1-BC10-480C-9F6A-DCB844193EE3Q34098110-8FFAF06D-875F-4E76-91FB-ED09532D5962Q34175129-56C7DACB-DDE9-42DE-B16D-91AA261BC88EQ34322575-D36E0FFB-CA47-4EEC-9DB6-9EE178B463C4Q34357786-AD190A83-E1A1-4E2A-A2B6-F7C8F1DF738EQ34510647-BB1605B6-CFCF-41CA-B901-549249564752Q34796583-84F29D8B-BA85-4795-9F93-0277B9B582A2Q35099257-3726A218-E3F9-4817-BDAB-53EBBE448B11Q35603660-13A1CF03-5B1F-461F-94F0-0717E0C95876Q35681975-0A9BD3C0-D2AE-4EB8-8D46-36BEE9BAF0EDQ36117667-FAD5322D-B0D0-4B9A-A5C2-205507CD410DQ36407003-11A55574-8D26-4B4C-9D35-BA9601F666C9Q36443927-230F4EFD-7659-4451-A8BF-6D3106ADAA4BQ36508759-63D91FCA-86A2-462D-90AE-A566474CDD1CQ36532522-0FCFF37C-F8C1-4453-A677-59E4D398AD18Q36849660-6CF6A1C0-44D6-4EC9-9929-5E3BB405F351Q36915318-87D16001-FC0C-41ED-BFE7-8C6CB7CFC55FQ36972936-E6EA4162-0CD7-4754-80BC-6C316492E736Q37201929-70A7E8FD-F74D-4945-8515-166ADE8FB9A7Q37225239-06AC9667-15AE-4A33-BA90-9EC95DF42C8AQ37325146-556A52CF-E4D4-4FBA-AF98-0971181DB035Q37667080-9E82E63F-2D1B-46CF-995C-52E597369243Q37690204-B0868E96-437E-46EC-A63F-F6C0D98FCD1FQ37708509-BCF7D2BA-8381-4E98-9620-D4F9817D335FQ37810222-AA977230-4CDB-4782-BC13-2FCEBADF64B6Q37815132-A4E5D4F9-15E1-42E7-8AD9-8EDDA350E740Q37898107-7056A5C5-51C7-4598-8272-3C107F90F128
P2860
Cell-free tumor DNA in blood plasma as a marker for circulating tumor cells in prostate cancer.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Cell-free tumor DNA in blood p ...... umor cells in prostate cancer.
@en
Cell-free tumor DNA in blood p ...... umor cells in prostate cancer.
@nl
type
label
Cell-free tumor DNA in blood p ...... umor cells in prostate cancer.
@en
Cell-free tumor DNA in blood p ...... umor cells in prostate cancer.
@nl
prefLabel
Cell-free tumor DNA in blood p ...... umor cells in prostate cancer.
@en
Cell-free tumor DNA in blood p ...... umor cells in prostate cancer.
@nl
P2093
P1476
Cell-free tumor DNA in blood p ...... tumor cells in prostate cancer
@en
P2093
Heidi Schwarzenbach
Imke Müller
Jean-Pierre Vendrell
Klaus Pantel
Nicolas Letang
Xavier Rebillard
P304
P356
10.1158/1078-0432.CCR-08-1910
P407
P577
2009-02-01T00:00:00Z